NCT02949895View on ClinicalTrials.gov

Study of BMS-986012 in Subjects With Small Cell Lung Caner

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

November 29, 2016

Primary Completion Date

August 29, 2017

Study Completion Date

August 29, 2017

Conditions
Small Cell Lung Cancer
Interventions
DRUG

BMS-986012

DRUG

Cisplatin

DRUG

Etoposide

Trial Locations (2)

1040045

Local Institution, Chuo-ku

5698686

Local Institution, Takatsuki-shi

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY